Personalized therapy for Helicobacter pylori : CYP2C19 genotype effect on first‐line triple therapy-Reference-Cited by-同舟云学术

Personalized therapy for Helicobacter pylori : CYP2C19 genotype effect on first‐line triple therapy

Published:2019-03-11 Issue:3 Volume:24 Page:e12574
ISSN:1083-4389
Container-title:Helicobacter
language:en
Short-container-title:Helicobacter

Author:

Arévalo Galvis Azucena¹^ORCID,Trespalacios Rangel Alba Alicia¹^ORCID,Otero Regino William²³^ORCID

Affiliation:

1. Laboratorio de Bacteriología Especial, Grupo de Enfermedades Infecciosas, Departamento de Microbiología, Facultad de Ciencias Pontificia Universidad Javeriana Bogotá Colombia

2. Unidad de Gastroenterología, Facultad de Medicina Universidad Nacional de Colombia Bogotá Colombia

3. Unidad de Gastroenterología Clínica Fundadores Bogotá Colombia

Funder

Pontificia Universidad Javeriana

Publisher

Wiley

Subject

Infectious Diseases,Gastroenterology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hel.12574

Reference58 articles.

1. Management ofHelicobacter pyloriinfection—the Maastricht V/Florence Consensus Report

2. Helicobacter pylori Infection When to Eradicate, How to Diagnose and Treat;Fischbach W;Dtsch Arztebl Int,2018

3. HelicobacterpyloriWorking Group.Helicobacter pylorieradication as a strategy for preventing gastric cancer. International Agency for Research on Cancer 150 cours Albert Thomas Lyon Cedex 08 France.2014;1‐59.

4. Treatment of Helicobacter pylori infection in 2018;O'Morain NR;Helicobacter,2018

5. New concepts of resistance in the treatment of Helicobacter pylori infections

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Refractoriness to anti‐Helicobacter pylori treatment attributed to phenotypic resistance patterns in patients with gastroduodenopathy in Guayaquil‐Ecuador;Helicobacter;2024-03

2. Empiric treatment vs susceptibility-guided treatment for eradicating H. pylori: Is it possible to change that paradigm using modern molecular methods?;Revista de Gastroenterología de México (English Edition);2022-07

3. Tratamiento empírico vs tratamiento basado en susceptibilidad para erradicar H.pylori: ¿es posible cambiar este paradigma usando métodos moleculares modernos?;Revista de Gastroenterología de México;2022-07

4. Omeprazole Treatment Failure in Gastroesophageal Reflux Disease and Genetic Variation at the CYP2C Locus;Frontiers in Genetics;2022-05-19

5. Efficacy of Phenotype-vs. Genotype-Guided Therapy Based on Clarithromycin Resistance for Helicobacter pylori Infection in Children;Frontiers in Pediatrics;2022-03-29